Chainalysis Files Lawsuit Against U.S. Over $94.6 Million ICE Contract with TRM Labs

cryptonews.ruPublicado em 2026-08-17Última atualização em 2026-08-17

Resumo

Blockchain analytics firm Chainalysis has filed a lawsuit against the U.S. government over an Immigration and Customs Enforcement (ICE) decision to award a non-compete contract worth approximately $94.6 million to its competitor TRM Labs. The contract, covering forensic software and investigative support services, is set to run from July 2026 to June 2027. Chainalysis claims the decision was "arbitrary, capricious, and unreasonable." It filed a complaint with the U.S. Court of Federal Claims on July 27, which has been sealed to protect confidential information. TRM Labs moved to intervene in the case on July 28. The court has scheduled government and TRM responses for a Friday, with oral hearings set for September 2. The government requested a ruling by September 10. Details of Chainalysis's specific objections or the legal remedy it seeks remain undisclosed in public documents.

Blockchain analytics company Chainalysis has filed a lawsuit against the U.S. government over a decision by Immigration and Customs Enforcement (ICE) to award a contract to competitor TRM Labs without a competitive tender.

On July 27, Chainalysis Government Solutions filed a complaint with the U.S. Court of Federal Claims. The corresponding petition became publicly available on Sunday through the CourtListener service's RECAP archive.

The federal contract notice lists the contract value at approximately $94.6 million; it includes forensic analysis software and investigative support services for Department of Homeland Security operational teams. The contract is for one year – from July 1, 2026, to June 30, 2027.

Chainalysis stated that ICE's decision was "arbitrary, capricious, and unreasonable." The company reported that it had submitted a description of its capabilities in response to ICE's notice of intent to procure forensic analysis software and support services from TRM.

Both companies provide blockchain analytics tools that government agencies use to track cryptocurrency transactions and investigate crimes.

According to the petition, the complaint remains under seal because it contains confidential and proprietary information from Chainalysis, as well as trade secrets. On July 31, the court granted Chainalysis permission to keep the complaint sealed.

TRM filed a motion to intervene in the case on July 28. The court scheduled the filing of responses from the government and TRM for Friday, with oral arguments set for September 2. The government requested a decision by September 10. The publicly available documents do not detail the specific objections from Chainalysis or the legal remedy being sought.

TRM Labs declined to comment. Chainalysis and ICE did not respond to requests for comment prior to publication.

Journal:Data leak of 54,000 wallet users, CLARITY's chances — just 10%: Hodler's Digest

end-content

Perguntas relacionadas

QWhy did Chainalysis file a lawsuit against the U.S. government?

AChainalysis filed a lawsuit because the U.S. Immigration and Customs Enforcement (ICE) awarded a contract to its competitor, TRM Labs, without a competitive bidding process.

QWhat is the value and timeframe of the contract in question between ICE and TRM Labs?

AThe contract is valued at approximately $94.6 million and is set for one year, from July 1, 2026, to June 30, 2027.

QWhat is the core accusation Chainalysis makes against ICE's decision regarding the TRM Labs contract?

AChainalysis accuses ICE's decision of being 'arbitrary, capricious, and unreasonable' for awarding the contract to TRM Labs without competition.

QWhy is Chainalysis's complaint currently sealed or kept confidential?

AThe complaint is sealed because it contains Chainalysis's confidential and proprietary information, as well as trade secrets.

QWhat type of services do both Chainalysis and TRM Labs provide to government agencies?

ABoth companies provide blockchain analytics tools that government agencies use to track cryptocurrency transactions and investigate crimes.

Leituras Relacionadas

Malta’s Regulator Takes Aim at Unlicensed Cryptocurrency Marketing Company

The Malta Financial Services Authority (MFSA) has issued a warning against DistributeX, an unlicensed entity involved in cryptocurrency marketing. Operating under various names, including Distributex Limited and DX, the firm has been conducting recruitment campaigns and maintaining physical offices in Malta without legal authorization or corporate registration. The regulator noted that despite having a digital presence via a website and mobile app, and physical offices in several Maltese localities, none of the entities associated with Distributex are registered in Malta. Under Maltese Virtual Financial Assets regulations, any firm offering crypto-related services from Malta must be licensed, which Distributex lacks. The MFSA's analysis identified operational features closely resembling high-risk multi-level marketing and potential pyramid schemes. These "red flags" include mandatory financial contributions from participants to join the platform and the use of referral commissions tied directly to recruiting new members. The firm promotes financial returns based on membership levels rather than genuine commercial activity. While not definitive proof of an illegal pyramid scheme, the MFSA warned that such models pose significant financial risks to investors. The alert references the regulator's general public advice on pyramid schemes disguised as MLM companies. The authority strongly urges the public to exercise extreme caution and avoid investing in unlicensed operations, as transactions through unregulated platforms strip consumers of legal protections and recourse in cases of fraud or financial loss.

cryptonews.ruHá 5m

Malta’s Regulator Takes Aim at Unlicensed Cryptocurrency Marketing Company

cryptonews.ruHá 5m

Anthropic CEO: AI will help defeat most diseases in 5–10 years

Dario Amodei, co-founder and CEO of Anthropic, predicts that artificial intelligence could enable humanity to cure or prevent most diseases within 5 to 10 years. He shared this view on social media, acknowledging it may seem overly optimistic but considers it realistic if the rapid development of powerful AI systems continues. Amodei clarifies this does not mean a single universal cure, but rather a scenario where AI dramatically accelerates biological research and therapy development. He elaborated on this concept in his essay "Machines of Loving Grace," estimating that sufficiently powerful AI could accelerate progress in biology and medicine by roughly tenfold, compressing a 50-100 year timeline into 5-10 years. Potential outcomes include significantly reducing cancer mortality, preventing or treating most genetic diseases, advancing the fight against Alzheimer's, and improving therapies for cardiovascular, autoimmune diseases, diabetes, and obesity. However, Amodei notes that real-world progress will still be constrained by the need for lab research, clinical trials, and regulatory approvals—steps AI cannot bypass. Anthropic is reportedly expanding its projects in biology and medicine, expecting initial signs of results soon and more substantial achievements in the coming years. The company has launched its "AI for Science" program, providing researchers access to its models for biology, genetics, and drug discovery projects. The statement is also viewed within a broader corporate context. Following a funding round valuing Anthropic at over $960 billion and projecting substantial revenue growth, investors are likely expecting tangible results beyond chatbots and code generation. Breakthroughs in biology and medicine represent a key argument to justify such a high market valuation. The open question remains whether AI-driven acceleration will lead to actual treatments or primarily enhanced data analysis tools for researchers.

cryptonews.ruHá 16m

Anthropic CEO: AI will help defeat most diseases in 5–10 years

cryptonews.ruHá 16m

A Critical Moment for Capital? The AI Narrative Shifts from Technology to Financing, Giants' Cash Flow Dries Up, Debt Markets Sound Alarm

The narrative of AI investment is shifting from a technology story to a capital expenditure story, and now to a financing story. This marks a "critical moment for capital," as noted by Bridgewater's Greg Jensen. Morgan Stanley forecasts that the total cost of AI infrastructure through 2028 will reach $3.2 trillion, with approximately $1.75 trillion expected to be raised from credit markets. However, free cash flow projections for major hyperscale cloud providers are declining sharply, with Oracle's 2027 forecast nearing -$40 billion. The bond market is already pricing in the rising risks. Apollo data shows AI-related bonds constitute 40% of long-duration supply. Credit spreads for hyperscalers have widened significantly this year—around 25 basis points for high-quality names—while the overall investment-grade market remained flat. Oracle's credit default swaps (CDS) have surged dramatically, indicating particular market concern. Renowned bond investor Jeff Gundlach sharply criticized financing plans using AI assets like GPUs as collateral, comparing them to "issuing 30-year ABS backed by bananas" due to the assets' rapid obsolescence. Although current balance sheets for hyperscalers appear strong, the future funding gap is widening. Morgan Stanley has nearly doubled its 2027 cloud capital expenditure growth forecast to 29%, amplifying the financing challenge. Purchasing commitments have exploded to $982 billion, with significant capital expenditures now existing off-balance-sheet, meaning true funding pressure is being underestimated.

marsbitHá 20m

A Critical Moment for Capital? The AI Narrative Shifts from Technology to Financing, Giants' Cash Flow Dries Up, Debt Markets Sound Alarm

marsbitHá 20m

Trading

Spot
活动图片